Clinical Evidence: Head-to-Head PT-141 Clinical Data PT-141 has the stronger regulatory evidence: FDA-approved as bremelanotide for HSDD in premenopausal women (2019) Phase III trials (RECONNECT) demonstrated statistically significant improvement in sexual desire and reduction in distress Efficacy shown in both male and female sexual dysfunction studies Well-established safety profile across large clinical trials Dose-limiting side effect: nausea (40%+ incidence at approved dose) Kisspeptin Clinical Data Kisspeptin has compelling but earlier-stage evidence: IVF oocyte maturation: Successfully used as an alternative to hCG in multiple clinical trials, with zero OHSS cases (Jayasena et al., 2014
These nutrient therapies can be combined with other wellness treatments or integrated into a customized plan based on your lifestyle, lab results, and goals
Aside from blogging , I run a social media marketing agency called Digital Circles collaborating with bloggers and brand/clients for online campaigns
Theory 2: GLP-1 is a miraculous moderation molecule, and it has docking portals all throughout the body that reduce inflammation
ErikaToo early to say!July 21, 2026It's still too early to see any major benefits, but so far, so good
Swirl gently to combine, dont shake vigorously, lest you damage the peptide